Annie McGuire's most recent trade in Veracyte Inc was a trade of 32,892 Common Stock done . Disclosure was reported to the exchange on March 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 32,892 | 127,598 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 26,314 | 153,912 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 35.29 per share. | 04 Mar 2026 | 4,994 | 96,370 (0%) | 0% | 35.3 | 176,256 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 36.34 per share. | 04 Mar 2026 | 1,664 | 94,706 (0%) | 0% | 36.3 | 60,469 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.01 per share. | 02 Mar 2026 | 6,902 | 101,364 (0%) | 0% | 36.0 | 248,541 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 50,999 | 119,133 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.75 per share. | 26 Feb 2026 | 10,867 | 108,266 (0%) | 0% | 38.7 | 421,096 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 43.13 per share. | 16 Dec 2025 | 10,639 | 67,860 (0%) | 0% | 43.1 | 458,836 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 43.68 per share. | 16 Dec 2025 | 100 | 67,760 (0%) | 0% | 43.7 | 4,368 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.16 per share. | 02 Dec 2025 | 3,052 | 79,921 (0%) | 0% | 46.2 | 140,880 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 47.10 per share. | 02 Dec 2025 | 720 | 79,201 (0%) | 0% | 47.1 | 33,909 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 47.51 per share. | 02 Dec 2025 | 702 | 78,499 (0%) | 0% | 47.5 | 33,352 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 05 Nov 2025 | 6,466 | 82,973 (0%) | 0% | 40 | 258,640 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 01 Oct 2025 | 2,160 | 89,439 (0%) | 0% | 35.0 | 75,608 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 33.69 per share. | 19 Sep 2025 | 2,283 | 91,599 (0%) | 0% | 33.7 | 76,920 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.11 per share. | 02 Sep 2025 | 3,507 | 93,882 (0%) | 0% | 30.1 | 105,596 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.74 per share. | 02 Jun 2025 | 3,505 | 97,003 (0%) | 0% | 26.7 | 93,724 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 30,200 | 100,508 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 33.69 per share. | 04 Mar 2025 | 1,142 | 70,308 (0%) | 0% | 33.7 | 38,476 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 13,466 | 86,705 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 27 Feb 2025 | 8,255 | 71,450 (0%) | 0% | 34.8 | 286,944 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.84 per share. | 27 Feb 2025 | 7,000 | 79,705 (0%) | 0% | 33.8 | 236,880 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 44.02 per share. | 04 Dec 2024 | 18,699 | 72,869 (0%) | 0% | 44.0 | 823,179 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.12 per share. | 02 Dec 2024 | 1,918 | 91,568 (0%) | 0% | 44.1 | 84,622 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.55 per share. | 02 Sep 2024 | 1,920 | 93,486 (0%) | 0% | 31.6 | 60,576 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.75 per share. | 02 Jun 2024 | 1,919 | 95,406 (0%) | 0% | 20.7 | 39,819 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 49,880 | 97,325 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.00 per share. | 02 Mar 2024 | 4,347 | 47,445 (0%) | 0% | 24 | 104,328 | Common Stock |
| Veracyte Inc | McGuire Annie | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.54 per share. | 02 Dec 2023 | 803 | 51,792 (0%) | 0% | 26.5 | 21,312 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.72 per share. | 02 Jun 2023 | 494 | 54,324 (0%) | 0% | 26.7 | 13,200 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 38,660 | 38,660 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 23,413 | 54,818 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.10 per share. | 02 Mar 2023 | 2,152 | 31,405 (0%) | 0% | 24.1 | 51,863 | Common Stock |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 18,248 | 18,248 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 10,702 | 33,557 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 42,175 | 42,175 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Annie McGuire | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 22,855 | 22,855 (0%) | 0% | 0 | Common Stock |